Sutro Biopharma (STRO) FCF Margin Growth (3y) (2020 - 2025)
Sutro Biopharma (STRO) FCF Margin Growth (3y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 15,064.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 723.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1,409.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Sutro Biopharma | 202.59 Mn | 61.16 Mn | - | -14,418.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -14,418.00 |
| Sep 30, 2025 | -67,908.00 |
| Jun 30, 2025 | -4,859.00 |
| Mar 31, 2025 | 22,248.00 |
| Dec 31, 2024 | -17,472.00 |
| Sep 30, 2024 | -45,524.00 |
| Jun 30, 2024 | 5,463.00 |
| Mar 31, 2024 | -28,804.00 |
| Dec 31, 2023 | 26,017.00 |
| Sep 30, 2023 | -6,890.00 |
| Jun 30, 2023 | -15,899.00 |
| Mar 31, 2023 | -22,316.00 |
| Dec 31, 2022 | -14,048.00 |
| Sep 30, 2022 | 39,491.00 |
| Jun 30, 2022 | 13,334.00 |
| Mar 31, 2022 | -37,860.00 |
| Dec 31, 2021 | -29,786.00 |
| Sep 30, 2021 | -89,371.00 |
| Jun 30, 2021 | 22,425.00 |
| Mar 31, 2021 | 4,610.00 |